Except for its ability to degrade the cartilage, MMP-1 has been discussed in relation to bone erosions [[35], [36], [37], [38]] and MMP-3 has been referred to as a biomarker prognosis and treatment responses in RA [39]. This evidence concerns the gene MMP1 and rheumatoid arthritis.